Welcome to LookChem.com Sign In|Join Free

CAS

  • or

13485-59-1

Post Buying Request

13485-59-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13485-59-1 Usage

Uses

L-Alanyl-L-proline is a dipeptide that contains a sterically constrained proline, a well-known turn inducer in proteins.

Definition

ChEBI: A dipeptide composed of L-alanine and L-proline joined by a peptide linkage.

Biochem/physiol Actions

Alanyl dipeptides such as ala-leu, ala-lys, ala-gly, ala-pro, ala-tyr and ala-phe may be used in physicochemical studies or to evaluate dipeptide separation technologies. Alanyl dipeptides may also be used for studying cell uptake mechanisms, dipeptide metabolism or cell growth supplementation benefits.

Check Digit Verification of cas no

The CAS Registry Mumber 13485-59-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,4,8 and 5 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 13485-59:
(7*1)+(6*3)+(5*4)+(4*8)+(3*5)+(2*5)+(1*9)=111
111 % 10 = 1
So 13485-59-1 is a valid CAS Registry Number.
InChI:InChI=1/C8H14N2O3/c1-5(9)7(11)10-4-2-3-6(10)8(12)13/h5-6H,2-4,9H2,1H3,(H,12,13)

13485-59-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (A1495)  L-Alanyl-L-proline  >98.0%(T)

  • 13485-59-1

  • 5g

  • 1,520.00CNY

  • Detail

13485-59-1Synthetic route

N-benzyloxycarbonyl-L-alanyl-L-proline
21027-01-0

N-benzyloxycarbonyl-L-alanyl-L-proline

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

Conditions
ConditionsYield
With acetic acid; 10% palladium on active carbon In methanol for 2h; Hydrogenation;98%
With hydrogen; palladium on activated charcoal In sodium hydroxide
(S)-1-((S)-2-Phosphonoamino-propionyl)-pyrrolidine-2-carboxylic acid
76166-63-7

(S)-1-((S)-2-Phosphonoamino-propionyl)-pyrrolidine-2-carboxylic acid

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

Conditions
ConditionsYield
With sodium chloride at 37℃; Rate constant; pH=7.5;
L-proline
147-85-3

L-proline

L-alanine N-carboxyanhydride
2224-52-4

L-alanine N-carboxyanhydride

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

Conditions
ConditionsYield
With potassium hydroxide; potassium carbonate In tetrahydrofuran; water at 5 - 10℃; for 0.25h;92 % Chromat.
N-tert-butoxycarbonyl-L-alanyl-L-proline
33300-72-0

N-tert-butoxycarbonyl-L-alanyl-L-proline

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

Conditions
ConditionsYield
With methoxybenzene; trifluoroacetic acid
With hydrogenchloride In ethyl acetate
With trifluoroacetic acid In dichloromethane at 0℃; for 3h;
Multi-step reaction with 2 steps
1: N,O-bis-(trimethylsilyl)-acetamide / acetonitrile / 0.5 h / 20 °C
2: tetra(n-butyl)ammonium hydroxide; water / methanol; tert-butyl methyl ether / 12 h
View Scheme
L-proline
147-85-3

L-proline

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: BOP; DIPEA / CH2Cl2
2: HCl / ethyl acetate
View Scheme
Multi-step reaction with 2 steps
2: TFA, anisole
View Scheme
L-proline ethyl ester monohydrochloride
33305-75-8

L-proline ethyl ester monohydrochloride

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 83 percent / ethyl acetate; dimethylformamide / 2 h / -10 - 20 °C
2: 85 percent / NaOH; HCl / methanol; CH2Cl2 / 3 h
3: 98 percent / acetic acid / 10 percent Pd/C / methanol / 2 h
View Scheme
N-carbobenzoxy-β-alanylproline ethyl ester

N-carbobenzoxy-β-alanylproline ethyl ester

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 85 percent / NaOH; HCl / methanol; CH2Cl2 / 3 h
2: 98 percent / acetic acid / 10 percent Pd/C / methanol / 2 h
View Scheme
(naphth-1-yl)methylamine
118-31-0

(naphth-1-yl)methylamine

1-pyruvyl-L-proline
76391-12-3

1-pyruvyl-L-proline

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

Conditions
ConditionsYield
With nitrogen; palladium In ethanol
With nitrogen; palladium In ethanol
1-pyruvyl-L-proline
76391-12-3

1-pyruvyl-L-proline

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

Conditions
ConditionsYield
With hydrogenchloride; nitrogen; hydroxylamine hydrochloride; sodium acetate; palladium hydroxide-on-carbon In ethanol; water
With hydrogenchloride; nitrogen; hydroxylamine hydrochloride; sodium acetate; palladium hydroxide-on-carbon In ethanol; water
Fmoc-Ala-Pro-OH
186023-44-9

Fmoc-Ala-Pro-OH

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

Conditions
ConditionsYield
With piperidine In N,N-dimethyl-formamide for 0.5h;
methyl (2S)-pyrrolidine carboxylate
2577-48-2

methyl (2S)-pyrrolidine carboxylate

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride / dichloromethane / 0.25 h / 0 °C
1.2: 24 h
2.1: lithium hydroxide / tetrahydrofuran; water / 5 h / 0 °C
3.1: trifluoroacetic acid / dichloromethane / 3 h / 0 °C
View Scheme
C16H30N2O5Si

C16H30N2O5Si

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

Conditions
ConditionsYield
With tetra(n-butyl)ammonium hydroxide; water In methanol; tert-butyl methyl ether for 12h;
L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

N-p-toluenesulfonyl-L-alanyl-L-proline

N-p-toluenesulfonyl-L-alanyl-L-proline

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane; aqueous sodium hydroxide (10 ml)-dioxane; water95.8%
L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

4-phenyl-butyric acid 4-guanidino-phenyl ester

4-phenyl-butyric acid 4-guanidino-phenyl ester

4-phenylbutanoyl-L-alanyl-L-proline

4-phenylbutanoyl-L-alanyl-L-proline

Conditions
ConditionsYield
With HEPES buffer; sodium chloride; calcium chloride; clostripain (EC 3.4.22.8) In water; N,N-dimethyl-formamide at 25℃; pH=8.0; Acylation;93%
L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

3-benzoylamino-propionic acid 4-guanidino-phenyl ester

3-benzoylamino-propionic acid 4-guanidino-phenyl ester

Bz-β-Ala-Ala-Pro-OH

Bz-β-Ala-Ala-Pro-OH

Conditions
ConditionsYield
With HEPES buffer; sodium chloride; calcium chloride; clostripain (EC 3.4.22.8) In water; N,N-dimethyl-formamide at 25℃; pH=8.0; Acylation;91%
ethanol
64-17-5

ethanol

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

L-alanyl-L-proline ethyl ester hydrochloride
88098-06-0

L-alanyl-L-proline ethyl ester hydrochloride

Conditions
ConditionsYield
With hydrogenchloride for 2h; Heating;90%
C27H33N9O9

C27H33N9O9

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

C29H42N10O9

C29H42N10O9

Conditions
ConditionsYield
With benzotriazol-1-ol; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 35℃; for 8h;81.39%
L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

N-(pyrazinecarbonyl)glycine azide
117904-03-7

N-(pyrazinecarbonyl)glycine azide

N--L-alanyl>-L-proline

N--L-alanyl>-L-proline

Conditions
ConditionsYield
With sodium methylate In N,N-dimethyl-formamide for 70h; Ambient temperature;72%
L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

Ethyl 4-(β-indolyl)-2-ketobutyrate
79155-18-3

Ethyl 4-(β-indolyl)-2-ketobutyrate

N-[1-ethoxycarbonyl-3-(3-indolyl)propyl]-L-alanyl-L-proline
79155-17-2

N-[1-ethoxycarbonyl-3-(3-indolyl)propyl]-L-alanyl-L-proline

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In ethanol at 25℃; under 2068.6 Torr;70%
2-oxo-4-phenylbutanoic acid ethyl ester
64920-29-2

2-oxo-4-phenylbutanoic acid ethyl ester

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

enalapril
75847-73-3

enalapril

Conditions
ConditionsYield
With hydrogen In ethanol at 45℃; under 735.074 - 772.577 Torr; Catalytic behavior; Kinetics; Solvent; Reagent/catalyst;70%
L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

(E)-ethyl-2-oxo-4-phenylbut-3-enoate
17451-20-6, 55674-14-1, 55629-96-4

(E)-ethyl-2-oxo-4-phenylbut-3-enoate

enalapril
75847-73-3

enalapril

Conditions
ConditionsYield
With 4 A molecular sieve; hydrogen; triethylamine; palladium In ethanol at 20℃; for 44h;65%
zinc(II) nitrate hexahydrate

zinc(II) nitrate hexahydrate

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

C16H26N4O6Zn

C16H26N4O6Zn

Conditions
ConditionsYield
In methanol for 1h;64%
copper(II) nitrate trihydrate

copper(II) nitrate trihydrate

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

C16H26CuN4O6

C16H26CuN4O6

Conditions
ConditionsYield
In methanol for 1h;62.35%
L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

4-[1-(3-Nitro-pyridin-2-ylamino)-meth-(Z)-ylidene]-2-phenyl-4H-oxazol-5-one

4-[1-(3-Nitro-pyridin-2-ylamino)-meth-(Z)-ylidene]-2-phenyl-4H-oxazol-5-one

(S)-1-{(S)-2-[(Z)-2-Benzoylamino-3-(3-nitro-pyridin-2-ylamino)-acryloylamino]-propionyl}-pyrrolidine-2-carboxylic acid

(S)-1-{(S)-2-[(Z)-2-Benzoylamino-3-(3-nitro-pyridin-2-ylamino)-acryloylamino]-propionyl}-pyrrolidine-2-carboxylic acid

Conditions
ConditionsYield
With sodium carbonate In water; acetonitrile for 2h; Heating;40%
L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

2-phenyl-4-(5-ethoxycarbonyl-2-methylthio-4-pyrimidinylamino)methylene-5(4H)-oxazolone
124211-85-4

2-phenyl-4-(5-ethoxycarbonyl-2-methylthio-4-pyrimidinylamino)methylene-5(4H)-oxazolone

4-{(Z)-2-Benzoylamino-2-[(S)-2-((S)-2-carboxy-pyrrolidin-1-yl)-1-methyl-2-oxo-ethylcarbamoyl]-vinylamino}-2-methylsulfanyl-pyrimidine-5-carboxylic acid ethyl ester

4-{(Z)-2-Benzoylamino-2-[(S)-2-((S)-2-carboxy-pyrrolidin-1-yl)-1-methyl-2-oxo-ethylcarbamoyl]-vinylamino}-2-methylsulfanyl-pyrimidine-5-carboxylic acid ethyl ester

Conditions
ConditionsYield
With sodium carbonate In water; acetonitrile for 2h; Heating;39%
L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

2-phenyl-4-(4-chloro-6-methyl-2-pyrimidinylamino)methylene-5(4H)-oxazolone
124594-30-5

2-phenyl-4-(4-chloro-6-methyl-2-pyrimidinylamino)methylene-5(4H)-oxazolone

(S)-1-{(S)-2-[(Z)-2-Benzoylamino-3-(4-chloro-6-methyl-pyrimidin-2-ylamino)-acryloylamino]-propionyl}-pyrrolidine-2-carboxylic acid

(S)-1-{(S)-2-[(Z)-2-Benzoylamino-3-(4-chloro-6-methyl-pyrimidin-2-ylamino)-acryloylamino]-propionyl}-pyrrolidine-2-carboxylic acid

Conditions
ConditionsYield
With sodium carbonate In water; acetonitrile for 2h; Heating;36%
trimethylsilyl cyanide
7677-24-9

trimethylsilyl cyanide

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

tert-butoxycarbonyl-D-prolinal
73365-02-3

tert-butoxycarbonyl-D-prolinal

C19H30N4O5

C19H30N4O5

Conditions
ConditionsYield
With ammonium chloride In methanol at 25℃; for 36h;36%
L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

pyrrolidino[1,2-a]-2,6-diazacycloheptane-1,5-dione

pyrrolidino[1,2-a]-2,6-diazacycloheptane-1,5-dione

Conditions
ConditionsYield
In acetic anhydride for 2.5h; Cyclization; Heating;33%
3-phenyl-propionaldehyde
104-53-0

3-phenyl-propionaldehyde

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

potassium cyanide
151-50-8

potassium cyanide

(S)-1-[(S)-2-(1-Cyano-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid
138247-41-3

(S)-1-[(S)-2-(1-Cyano-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid

Conditions
ConditionsYield
With acetic acid In methanol
4-phthalimidobutanal
3598-60-5

4-phthalimidobutanal

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

potassium cyanide
151-50-8

potassium cyanide

(S)-1-{(S)-2-[1-Cyano-4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butylamino]-propionyl}-pyrrolidine-2-carboxylic acid

(S)-1-{(S)-2-[1-Cyano-4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butylamino]-propionyl}-pyrrolidine-2-carboxylic acid

Conditions
ConditionsYield
With acetic acid In methanol for 48h;
3,3-dimethyl acrylaldehyde
107-86-8

3,3-dimethyl acrylaldehyde

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

potassium cyanide
151-50-8

potassium cyanide

(S)-1-[(S)-2-(1-Cyano-3-methyl-but-2-enylamino)-propionyl]-pyrrolidine-2-carboxylic acid

(S)-1-[(S)-2-(1-Cyano-3-methyl-but-2-enylamino)-propionyl]-pyrrolidine-2-carboxylic acid

Conditions
ConditionsYield
With acetic acid In methanol for 48h;
2-(benzoylamino)acetaldehyde
6542-76-3

2-(benzoylamino)acetaldehyde

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

potassium cyanide
151-50-8

potassium cyanide

(S)-1-[(S)-2-(2-Benzoylamino-1-cyano-ethylamino)-propionyl]-pyrrolidine-2-carboxylic acid

(S)-1-[(S)-2-(2-Benzoylamino-1-cyano-ethylamino)-propionyl]-pyrrolidine-2-carboxylic acid

Conditions
ConditionsYield
With acetic acid In methanol for 48h;
In methanol for 72h;
N-tert.butyloxycarbonyl-alanine pentafluorophenyl ester
50903-48-5

N-tert.butyloxycarbonyl-alanine pentafluorophenyl ester

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

N-tert-butyloxycarbonyl-alanyl-alanyl-proline
63769-98-2

N-tert-butyloxycarbonyl-alanyl-alanyl-proline

Conditions
ConditionsYield
In 1,4-dioxane for 24h;
2-oxo-4-phenylbutanoic acid ethyl ester
64920-29-2

2-oxo-4-phenylbutanoic acid ethyl ester

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

A

enalapril
75847-73-3

enalapril

B

enalapril
76420-74-1

enalapril

Conditions
ConditionsYield
nickel Product distribution; var. catalysts and reducing agents, diastereomeric ratio;
With 3 A molecular sieve; hydrogen; nickel In ethanol at 23 - 28℃; under 2068.6 Torr; for 18h; Title compound not separated from byproducts;
With potassium fluoride; 3 A molecular sieve; hydrogen; acetic acid; nickel In ethanol at 22℃; under 760 Torr; for 18h; Yield given; Yields of byproduct given;
2-oxo-4-phenylbutanoic acid ethyl ester
64920-29-2

2-oxo-4-phenylbutanoic acid ethyl ester

L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

(S)-1-{(S)-2-[1-Ethoxycarbonyl-3-phenyl-prop-(E)-ylideneamino]-propionyl}-pyrrolidine-2-carboxylic acid
90414-32-7

(S)-1-{(S)-2-[1-Ethoxycarbonyl-3-phenyl-prop-(E)-ylideneamino]-propionyl}-pyrrolidine-2-carboxylic acid

Conditions
ConditionsYield
With 4 A molecular sieve In ethanol
L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

Boc-L-Pro-H
69610-41-9

Boc-L-Pro-H

potassium cyanide
151-50-8

potassium cyanide

C19H30N4O5

C19H30N4O5

Conditions
ConditionsYield
In methanol for 96h;
L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

Boc-L-phenylalaninal
72155-45-4

Boc-L-phenylalaninal

potassium cyanide
151-50-8

potassium cyanide

(S)-1-[(S)-2-((S)-2-tert-Butoxycarbonylamino-1-cyano-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid
94670-41-4, 94730-84-4

(S)-1-[(S)-2-((S)-2-tert-Butoxycarbonylamino-1-cyano-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid

Conditions
ConditionsYield
With acetic acid In methanol for 72h;
L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

potassium cyanide
151-50-8

potassium cyanide

3-[(tert-butoxycarbonyl)amino]-4-phenylbutanaldehyde
130944-47-7

3-[(tert-butoxycarbonyl)amino]-4-phenylbutanaldehyde

(S)-1-[(S)-2-((S)-3-tert-Butoxycarbonylamino-1-cyano-4-phenyl-butylamino)-propionyl]-pyrrolidine-2-carboxylic acid

(S)-1-[(S)-2-((S)-3-tert-Butoxycarbonylamino-1-cyano-4-phenyl-butylamino)-propionyl]-pyrrolidine-2-carboxylic acid

Conditions
ConditionsYield
With acetic acid In methanol for 48h;
L-alanyl-L-proline
13485-59-1

L-alanyl-L-proline

potassium cyanide
151-50-8

potassium cyanide

(3S)-3-benzamido-4-phenylbutanal
94670-46-9

(3S)-3-benzamido-4-phenylbutanal

(S)-1-[(S)-2-((S)-3-Benzoylamino-1-cyano-4-phenyl-butylamino)-propionyl]-pyrrolidine-2-carboxylic acid

(S)-1-[(S)-2-((S)-3-Benzoylamino-1-cyano-4-phenyl-butylamino)-propionyl]-pyrrolidine-2-carboxylic acid

Conditions
ConditionsYield
With acetic acid In methanol for 72h;

13485-59-1Relevant articles and documents

N(in)-diphenylphosphinothioyltryptophan, a useful derivative for peptide synthesis by the methanesulphonic acid-thioanisole system and fluoride ion deprotection methods

Kiso,Kimura,Shimokura,Narukami

, p. 287 - 289 (1988)

-

Synthesis, characterization and in vitro DNA binding and cleavage studies of Cu(II)/Zn(II) dipeptide complexes

Arjmand, Farukh,Jamsheera,Mohapatra

, p. 75 - 85 (2013)

Novel dipeptide complexes Cu(II)?Val-Pro (1), Zn(II)?Val-Pro (2), Cu(II)?Ala-Pro (3) and Zn(II)?Ala-Pro (4) were synthesized and thoroughly characterized using different spectroscopic techniques including elemental analyses, IR, NMR, ESI-MS and molar conductance measurements. The solution stability study carried out by UV-vis absorption titration over a broad range of pH proved the stability of the complexes in solution. In vitro DNA binding studies of complexes 1-4 carried out employing absorption, fluorescence, circular dichroism and viscometric studies revealed the binding of complexes to DNA via groove binding. UV-vis titrations of 1-4 with mononucleotides of interest viz., 5′-GMP and 5′-TMP were also carried out. The DNA cleavage activity of the complexes 1 and 2 were ascertained by gel electrophoresis assay which revealed that the complexes are good DNA cleavage agents and the cleavage mechanism involved a hydrolytic pathway. Furthermore, in vitro antitumor activity of complex 1 was screened against human cancer cell lines of different histological origin.

A process for preparing a renin - angiotensin - aldosterone system dual inhibitor compound of intermediate

-

Paragraph 0062; 0063; 0064; 0068; 0069; 0070, (2017/04/28)

The invention relates to an intermediate compound for preparing RAAS (renin-angiotensin-aldosterone system) dual inhibitor compounds. RAAS dual inhibitors can be used for treating diseases related to an RAAS such as high blood pressure and heart diseases.

RAAS system as a dual inhibitor compounds

-

Paragraph 0051; 0052-0054, (2017/02/28)

The invention discloses a compound used as a dual inhibitor for RAAS (rennin angiotensin aldosterone system) and particularly relates to a compound shown in formula (I), a stereisomer thereof or a pharmaceutically acceptable salt thereof. The compound can be used for treating and blocking RAS-associated diseases such as hypertension and heart disease, can be used for preventing or treating hypertension, congestive heart failure, pulmonary hypertension, renal insufficiency, renal ischemia, kidney failure, renal fibrosis, cardiac insufficiency, cardiac hypertrophy, cardiac fibrosis, myocardial ischemia, cardiomyopathy, glomerulonephritis, renal colic, complications such as nephropathy caused by diabetes, vasculopathy, vasculopathy, glaucoma, intraocular pressure elevation, atherosis, restenosis after revascularization, complications after blood vessel or cardiac operation, erectile dysfunction, hyperaldosteronism, lung fibrosis, scleroderma, anxiety, cognitive disorder, complications caused by immunosuppressor treatment as well as other known diseases associated with the rennin angiotensin aldosterone system.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13485-59-1